Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Mar 11, 2019 11:54 AM IST | Source: PTI

USFDA concludes inspection of Unichem Lab's Ghaziabad facility

The US Food and Drug Administration (USFDA) conducted inspection of the company's Ghaziabad facility from March 3-8, 2019, and it has been successfully concluded without any USFDA form 483 issued, Unichem Laboratories said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Unichem Laboratories on Monday said the US health regulator has concluded inspection of its Ghaziabad facility without making any observations.

The US Food and Drug Administration (USFDA) conducted inspection of the company's Ghaziabad facility from March 3-8, 2019, and it has been successfully concluded without any USFDA form 483 issued, Unichem Laboratories said in a BSE filing.

A form 483 is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection.

Close
Shares of Unichem Laboratories Ltd were trading 2.70 per cent higher Rs 203.25 apiece on the BSE.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Mar 11, 2019 11:49 am
Sections
Follow us on